Synopsis
Synopsis
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
Europe
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Bellacarotin
2. Beta Carotene
3. Betacarotene
4. Carotaben
5. Carotene, Beta
6. Max Caro
7. Max-caro
8. Maxcaro
9. Provatene
10. Solatene
11. Vetoron
1. 7235-40-7
2. Beta Carotene
3. Beta,beta-carotene
4. Betacarotene
5. Solatene
6. Provitamin A
7. Carotaben
8. Provatene
9. Serlabo
10. All-trans-beta-carotene
11. Food Orange 5
12. Kpmk
13. Lucaratin
14. Betavit
15. Natural Yellow 26
16. Karotin
17. Provatenol
18. Beta-karotin
19. B-carotene
20. B,b-carotene
21. .beta.-carotene
22. C.i. Food Orange 5
23. .beta.,.beta.-carotene
24. Zlut Prirodni 26
25. All-trans-.beta.-carotene
26. Ci Food Orange 5
27. Carotene,beta
28. Beta-carotin
29. Beta -carotene
30. Beta;-carotene
31. Ci 40800
32. Ci 75130
33. .beta. Carotene
34. Lucarotin 30sun
35. C.i. 75130
36. Nsc 62794
37. Beta, Beta-carotene
38. Betacarotene [inn]
39. (all-e)-1,1'-(3,7,12,16-tetramethyl-1,3,5,7,9,11,13,15,17-octadecanonaene-1,18-diyl)bis(2,6,6-trimethylcyclohexene)
40. 1,3,3-trimethyl-2-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-3,7,12,16-tetramethyl-18-(2,6,6-trimethylcyclohexen-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaenyl]cyclohexene
41. 116-32-5
42. Ins-160a(iii)
43. Ins No.160a(iii)
44. Caroten Base 35468
45. Rovimix .beta.-carotene
46. E-160a(iii)
47. Mls001066383
48. 01yae03m7j
49. 2,2'-((1e,3e,5e,7e,9e,11e,13e,15e,17e)-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaene-1,18-diyl)bis(1,3,3-trimethylcyclohex-1-ene)
50. Chebi:17579
51. Nsc62794
52. Betacarotene (inn)
53. Nsc-62794
54. 1,1'-(3,7,12,16-tetramethyl-1,3,5,7,9,11,13,15,17-octadecanonaene-1,18-diyl)bis(2,6,6-trimethylcyclohexene), (all E)-
55. Ncgc00096081-01
56. Smr000112037
57. C.i.-40800
58. Solatene (caps)
59. Karotin [czech]
60. Cyclohexene, 1,1'-(3,7,12,16-tetramethyl-1,3,5,7,9,11,13,15,17-octadecanonaene-1,18-diyl)bis(2,6,6-trimethyl-, (all-e)-
61. .beta.-carotene, All-trans-
62. Betacarotenum [latin]
63. Beta Carotene [usan]
64. Betacaroteno
65. Betacaroteno [spanish]
66. Betacarotenum
67. Mfcd00001556
68. Beta-carotene, All-trans-
69. Betacarotenum [inn-latin]
70. Betacaroteno [inn-spanish]
71. Zlut Prirodni 26 [czech]
72. 1,1'-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaene-1,18-diyl]bis(2,6,6-trimethylcyclohexene)
73. Trans-beta-carotene
74. Ccris 3245
75. Hsdb 3264
76. Diet,beta-carotene Supplementation
77. E160a
78. Sr-01000763803
79. Einecs 230-636-6
80. Beta Carotene [usan:usp]
81. Unii-01yae03m7j
82. Lucarotin
83. Lurotin
84. Beta-carotine
85. All-e-b-carotene
86. Rovimix B-carotene
87. Carotene, .beta.
88. Solatene (tn)
89. Cyclohexene, 1,1'-(3,7,12,16-tetramethyl-1,3,5,7,9,11,13,15,17-octadecanonaene-1,18-diyl)bis[2,6,6-trimethyl-, (all-e)-
90. I(2)-carotene
91. Carotene Base 80s
92. All-trans-b-carotene
93. Beta Carotene Natural
94. Beta Carotene (usp)
95. Trans-.beta.-carotene
96. Carotene, Provitamin A
97. All Trans Beta-carotene
98. B-carotene - 30%
99. All-e-.beta.-carotene
100. All-epsilon-beta-carotene
101. Dsstox_cid_253
102. Spectrum5_000505
103. .beta., .beta.-carotene
104. Bmse000832
105. Ec 230-636-6
106. C40h56 (beta-carotene)
107. (9z,13z)-beta-carotene
108. Beta Carotene [dsc]
109. Beta-carotene [fcc]
110. Chembl1293
111. Dsstox_rid_75466
112. Bidd:pxr0110
113. Dsstox_gsid_20253
114. Beta Carotene [hsdb]
115. Beta-carotene [inci]
116. Betacarotene [mart.]
117. Bspbio_003404
118. Beta Carotene [vandf]
119. Betacarotene [who-dd]
120. Carotene,beta [vandf]
121. .beta.-carotene [mi]
122. Beta Carotene [usp-rs]
123. Dtxsid3020253
124. Bdbm54988
125. Cid_5280489
126. Hms501a12
127. .beta.,.beta.-carotene, Neo B
128. Betacarotene [ep Impurity]
129. Ci 40800 [inci]
130. Ci 75130 [inci]
131. Hms2091m17
132. Pharmakon1600-01500143
133. Betacarotene [ep Monograph]
134. Beta Carotene [orange Book]
135. Hy-n0411
136. Zinc6845076
137. Beta-carotene, >=97.0% (uv)
138. Tox21_111557
139. Ccg-36062
140. Lmpr01070001
141. Nsc755910
142. S1767
143. Beta Carotene [usp Monograph]
144. Akos015896682
145. Ac-1869
146. Db06755
147. Nsc-755910
148. Sdccgmls-0066579.p001
149. Idi1_000330
150. Ncgc00096081-02
151. As-13354
152. Xc175229
153. Cas-7235-40-7
154. Sbi-0051295.p003
155. N1547
156. Sw220035-1
157. C02094
158. D03101
159. Ab00051925_06
160. Ab00051925_07
161. Beta-carotene, Vetec(tm) Reagent Grade, >=93%
162. Q306135
163. Q-200706
164. Sr-01000763803-2
165. Sr-01000763803-3
166. Sr-01000763803-4
167. Beta-carotene (constituent Of Spirulina) [dsc]
168. Beta-carotene, Type I, Synthetic, >=93% (uv), Powder
169. 89648336-f9b2-44a0-9bf8-62e73369cb9b
170. Beta Carotene, United States Pharmacopeia (usp) Reference Standard
171. Beta-carotene, Type Ii, Synthetic, >=95% (hplc), Crystalline
172. Beta-carotene (constituent Of Lycopene And Tomato Extract Containing Lycopene) [dsc]
173. Beta-carotene, Pharmaceutical Secondary Standard; Certified Reference Material
174. Cyclohexane,1,1'-(3,7,12,16-tetramethyl-1,18-octadecanediyl)bis[2,2,6-trimethyl-
175. (all-e)-1,1'-(3,7,12,16-tetramethyl-1,3,5, 7,9,11,13,15,17-octadecanonaene-1,18-diyl)bis[2,6, 6-trimethylcyclohexene]
176. (all-e)-1,1'-(3,7,12,16-tetramethyl-1,3,5,7,9,11,13,15,17-octadecanonaene-1,18-diyl)bis
177. (all-e)-1,1'-(3,7,12,16-tetramethyl-1,3,5,7,9,11,13,15,17-octadecanonaene-1,18-diyl)bis[2,6,6-trimethyl-cyclohexene
178. 1,18-bis(2,6,6-trimethyl-1-cyclohexenyl)-3,7,12,16-tetramethyl-1,3,5,7,9,11,13,15,17-octadecanonene
| Molecular Weight | 536.9 g/mol |
|---|---|
| Molecular Formula | C40H56 |
| XLogP3 | 13.5 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 0 |
| Rotatable Bond Count | 10 |
| Exact Mass | 536.438201786 g/mol |
| Monoisotopic Mass | 536.438201786 g/mol |
| Topological Polar Surface Area | 0 Ų |
| Heavy Atom Count | 40 |
| Formal Charge | 0 |
| Complexity | 1120 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 9 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antioxidants
National Library of Medicine's Medical Subject Headings online file (MeSH, 1999)
THERAPY WITH ORAL BETA-CAROTENE IN PATIENT WITH POLYMORPHOUS LIGHT ERUPTION; COMPLETE REMISSION OCCURRED IN 32% (6/19) TREATED WITH BETA-CAROTENE.
PMID:427019 PARRISH JA ET AL; BR J DERMATOL 100 (2): 187 (1979)
MEDICATION (VET): VITAMIN A PRECURSOR FOR ALL SPECIES EXCEPT CATS.
Budavari, S. (ed.). The Merck Index - Encyclopedia of Chemicals, Drugs and Biologicals. Rahway, NJ: Merck and Co., Inc., 1989., p. 282
The effects of chronic oral administration of beta-carotene, a carotenoid partially metabolized to retinol, on plasma lipid concentrations have not been well studied; therefore, 61 subjects were studied over 12 mo while they were enrolled in a skin cancer prevention study in which patients were randomly assigned to receive either placebo (n = 30) or 50 mg beta-carotene/day orally (n = 31). At study entry and 1 yr later, fasting blood samples were obtained for measurement of triglycerides, total cholesterol, high density lipoprotein cholesterol, retinol, and beta-carotene. Retinol concentrations changed minimally in both groups; beta-carotene concentration increased an average of 12.1 + or - 47 nmol/L in the placebo group and 4279 + or - 657 nmol/l in the active treatment group. Both groups experienced similar small increases in triglyceride and total cholesterol concentrations and small decreases in high density lipoprotein cholesterol. Daily oral administration of 50 mg beta-carotene/day did not affect plasma lipid concentrations.
PMID:2000818 Nierenberg DW et al; Am J Clin Nutr 53 (3): 652-4 (1991)
For more Therapeutic Uses (Complete) data for BETA-CAROTENE (10 total), please visit the HSDB record page.
NOT EFFECTIVE AS SUNSCREEN IN NORMAL INDIVIDUALS & SHOULD NOT BE USED FOR THAT PURPOSE ... USED WITH CAUTION IN PT WITH IMPAIRED RENAL OR HEPATIC FUNCTION BECAUSE SAFE USE ... HAS NOT BEEN ESTABLISHED.
American Society of Hospital Pharmacists. Data supplied on contract from American Hospital Formulary Service and other current ASHP sources., p. 1976
Beta carotene is well tolerated. Carotenodermia is usually the only adverse effect. Patients should be forewarned that carotenodermia will develop after 2-6 weeks of therapy, usually first noticed as yellowness of the palms of the hands or soles of the feet and to a lesser extent of the face. Some patients may experience loose stools during beta carotene therapy, but this is sporadic and may not require discontinuance of therapy. Ecchymoses and arthralgia have been reported rarely
McEvoy, G.K. (ed.). American Hospital Formulary Service. AHFS Drug Information. American Society of Health-System Pharmacists, Bethesda, MD. 2006., p. 3555
Beta carotene should be used with caution in patients with impaired renal or hepatic function because safe use of the drug in the presence of these conditions has not been established. Although abnormally high blood concentrations of vitamin A do not occur during beta carotene therapy, patients receiving beta carotene should be advised against taking supplementary vitamin A because beta carotene will fulfill normal vitamin A requirements. Patients should be cautioned that large quantities of green or yellow vegetables or their juices or extracts are not suitable substitutes for crystalline beta carotene because consumption of excessive quantities of these vegetables may cause adverse effects such as leukopenia or menstrual disorders. Patients should be warned that the protective effect of beta carotene is not total and that they may still develop considerable burning and edema after sufficient exposure to sunlight. Each patient must establish his own time limit of exposure.
McEvoy, G.K. (ed.). American Hospital Formulary Service. AHFS Drug Information. American Society of Health-System Pharmacists, Bethesda, MD. 2006., p. 3556
There are no adequate and controlled studies to date in humans. Beta carotene should be used during pregnancy only when the potential benefits justify the possible risks to the fetus. The effect of beta carotene on fertility in humans is not known.
McEvoy, G.K. (ed.). American Hospital Formulary Service. AHFS Drug Information. American Society of Health-System Pharmacists, Bethesda, MD. 2006., p. 3556
For more Drug Warnings (Complete) data for BETA-CAROTENE (11 total), please visit the HSDB record page.
Beta-carotene is FDA approved to be used as a nutrient supplement and to be even added in infant formula as a source of vitamin A. It is also approved to be used as a color additive for food products, drugs (with the label of "only as a color additive") and cosmetics. It is used commonly for the reduction of photosensitivity in patients with erythropoietic protoporphyria and other photosensitivity diseases.
Oral administration of beta-carotene increases the serum concentration of beta-carotene by 60% but it does not change the concentration found in the heart, liver or kidneys. In vitro studies in hepatocytes have shown that beta-carotene ameliorates oxidative stress, enhances antioxidant activity and decreases apoptosis. Other than the antioxidant activities, some other actions have been correlated to beta-carotene. It is thought to have detoxifying properties, as well as to help increase resistance to inflammation and infection and increase immune response and enhance RNA production.
Provitamins
Precursor forms of vitamins. (See all compounds classified as Provitamins.)
A - Alimentary tract and metabolism
A11 - Vitamins
A11C - Vitamin a and d, incl. combinations of the two
A11CA - Vitamin a, plain
A11CA02 - Betacarotene
D - Dermatologicals
D02 - Emollients and protectives
D02B - Protectives against uv-radiation
D02BB - Protectives against uv-radiation for systemic use
D02BB01 - Betacarotene
Absorption
After administration of beta-carotene, some of the administered dose is absorbed into the circulatory system unchanged and stored in the fat tissue. The coadministration of beta-carotene and a high-fat content diet is correlated to a better absorption of beta-carotene. The absorption is also dependent on the isomeric form of the molecule where the cis conformation seems to present a higher bioavailability. The absorption of beta-carotene is thought to be performed in 6-7 hours. The reported AUC of beta-carotene when administered orally from 0 to 440 hours after initial administration was reported to be 26.3 mcg.h/L. The maximal concentration of beta-carotene is attained in a dual pharmacokinetic profile after 6 hours and again after 32 hours with a concentration of 0.58 micromol/L.
Route of Elimination
The unabsorbed carotene is excreted in feces. It is also excreted in feces and urine as metabolites. The consumption of dietary fiber can increase the fecal excretion of fats and other fat-soluble compounds such as beta-carotene.
Volume of Distribution
No pharmacokinetic studies have been performed regarding the volume of distribution of beta-carotene.
Clearance
The clearance rate of beta-carotene administered orally is 0.68 nmol/L each hour.
Carotenoids are absorbed and transported via lymphatics to the liver. They circulate in association with lipoproteins, and are found in liver, adrenal, testes, and adipose tissue, and can be converted to vitamin A in numerous tissues, including the liver. Some beta carotene is absorbed as such and circulates in association with lipoproteins; it apparently partitions into body lipids and can be converted to vitamin A in numerous tissues, including the liver.
Hardman, J.G., L.E. Limbird, P.B., A.G. Gilman. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 10th ed. New York, NY: McGraw-Hill, 2001., p. 1781
Absorption of beta-carotene depends on the presence of dietary fat and bile in the intestinal tract.
Thomson/Micromedex. Drug Information for the Health Care Professional. Volume 1, Greenwood Village, CO. 2006.
Unchanged beta-carotene is found in various tissues, primarily fat tissues, adrenal glands, and ovaries. Small concentrations are found in the liver.
Thomson/Micromedex. Drug Information for the Health Care Professional. Volume 1, Greenwood Village, CO. 2006.
Only about one-third of beta-carotene or other carotenoids is absorbed by human beings. The absorption of carotenoids takes place in a relatively nonspecific fashion and depends upon the presence of bile and absorbable fat in the intestinal tract; it is greatly decreased by steatorrhea, chronic diarrhea, and very-low-fat diets.
Hardman, J.G., L.E. Limbird, P.B., A.G. Gilman. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 10th ed. New York, NY: McGraw-Hill, 2001., p. 1781
For more Absorption, Distribution and Excretion (Complete) data for BETA-CAROTENE (9 total), please visit the HSDB record page.
Beta-carotene is broken down in the mucosa of the small intestine and liver by beta-carotene dioxygenase to retinal which is a form of vitamin A. The function of this enzyme is vital as it decides if the beta-carotene is transformed to vitamin A or if it circulates in the plasma as beta-carotene. Less than a quarter of the ingested beta-carotene from root vegetables and about half of the beta-carotene from leafy green vegetables are converted to vitamin A.
A portion of the beta-carotene is converted to retinol in the wall of the small intestine, principally by its initial cleavage at the 15,15' double bond to form two molecules of retinal. Some of the retinal is further oxidized to retinoic acid; only one-half is reduced to retinol, which is then esterified and transported in the lymph. ...
Hardman, J.G., L.E. Limbird, P.B., A.G. Gilman. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 10th ed. New York, NY: McGraw-Hill, 2001., p. 1781
Approximately 20 to 60% of beta-carotene is metabolized to retinaldehyde and then converted to retinol, primarily in the intestinal wall. A small amount of beta-carotene is converted to vitamin A in the liver. The proportion of beta-carotene converted to vitamin A diminishes inversely to the intake of beta-carotene, as long as the dosages are higher than one to two times the daily requirements. High doses of beta-carotene do not lead to abnormally high serum concentrations of vitamin A.
Thomson/Micromedex. Drug Information for the Health Care Professional. Volume 1, Greenwood Village, CO. 2006.
Beta carotene may be converted to 2 molecules of retinal by cleavage at the 15-15' double bond in the center of the molecule. Most of the retinal is reduced to retinol which is then conjugated with glucuronic acid and excreted in urine and feces. Some retinal may be further oxidized to retinoic acid which can be decarboxylated and further metabolized, secreted into bile, and excreted in feces as the glucuronide.
McEvoy, G.K. (ed.). American Hospital Formulary Service. AHFS Drug Information. American Society of Health-System Pharmacists, Bethesda, MD. 2006., p. 3556
Two pathways have been suggested for the conversion of carotenoids to vitamin A in mammals, central cleavage and excentric cleavage. An enzyme, beta-carotenoid-15,15'-dioxygenase, has been partly purified from the intestines of several species and has been identified in several other organs and species. The enzyme, which converts beta-carotene into two molecules of retinal in good yield, requires molecular oxygen and is inhibited by sulfhydryl binding reagents and iron binding reagents. Most provitamin A carotenoids, including the beta-apo-carotenals, are cleaved to retinal by this enzyme. Its maximal activity in the rabbit is approximately 200 times that required to meet nutritional needs but is less than 50% of that expected to produce signs of vitamin A toxicity. Excentric cleavage unquestionably occurs in plants and some microorganisms and might occur in mammals. Thus far, however, carotenoid dioxygenase with excentric bond specificity has been identified in mammals, the yield of beta-apo-carotenals from beta-carotene in vivo and in vitro is very low, and beta-apo-carotenals are formed nonbiologically from beta-carotene.
PMID:2643691 Olson JA; J Nutr 119 (1): 105-8 (1989)
The carotenes are not converted to retinol very rapidly, so that overdoses of the carotenes do not cause vitamin A toxicity. /Carotenes/
Shoden & Griffin; Fundamentals of Clinical Nutrition: 77 (1980)
The apparent half-life of beta-carotene is of 6-11 days after initial administration.
Beta-carotene is an antioxidant that presents significant efficacy against the reactive oxygen species singlet oxygen. Beta-carotene acts as a scavenger of lipophilic radicals within the membranes of every cell compartments. It also presents an oxidative modification of LDL. The presence of long chains of conjugated double bonds is responsible for its antioxidative properties by allowing beta-carotene to chelate oxygen-free radicals and dissipate their energy. The chelation of free radicals inhibits the peroxidation of lipids. The effect of beta-carotene in the immune response is thought to be related to the direct effect on the thymus which increases the production of immune cells.
IN HEMATOPORPHYRIN PHOTOSENSITIZED MICE BETA-CAROTENE SHOWED PHOTOPROTECTION WAS DUE TO FREE RADICAL SCAVENGING OR SINGLET O QUENCHING BUT ALSO A POSSIBLE ROLE OF 400 NM LIGHT ABSORPTION, A PROPERTY OF BETA-CAROTENE.
PMID:839088 MOSHELL AN, BJORNSON L; J INVEST DERMATOL 68 (3): 157 (1977)
Beta carotene protects patients with erythropoietic protoporphyria against severe photosensitivity reactions (burning sensation, edema, erythema, pruritus, and/or cutaneous lesions). The drug has no effect on the basic biochemical abnormality of erythropoietic protoporphyria (eg, erythrocyte, plasma, and stool concentrations of protoporphyrins are not altered by the drug). The precise mechanism by which the drug exerts photoprotection has not been established. There is some evidence that photosensitizers may act through the formation of singlet excited oxygen and/or free radicals. Since in vitro studies indicate that beta carotene can quench free radicals and singlet excited oxygen, this may be the mechanism by which the drug acts. It is unlikely that beta carotene acts simply as a filter for the wavelengths of light that induce phototoxic effects.
McEvoy, G.K. (ed.). American Hospital Formulary Service. AHFS Drug Information. American Society of Health-System Pharmacists, Bethesda, MD. 2006., p. 3556
beta-Carotene inhibits UV-B carcinogenesis. beta-Carotene is an excellent quencher of singlet oxygen, and can quench free radicals. beta-Carotene has been shown to quench singlet oxygen/free radical reactions in the skin of porphyric mice, and has been found to quench excited species formed on irradiation of mouse skin by UV-B.
PMID:1881965 Black HS, Mathews-Roth MM; Photochem Photobiol 53 (5): 707-16 (1991)
API SUPPLIERS
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7653
Submission : 1988-08-24
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4390
Submission : 1982-01-14
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5793
Submission : 1985-04-10
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5851
Submission : 1985-05-20
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5865
Submission : 1985-05-17
Status : Inactive
Type : II
Certificate Number : R1-CEP 2010-383 - Rev 01
Issue Date : 2019-06-14
Type : Chemical
Substance Number : 1069
Status : Valid
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5865
Submission : 1985-05-17
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5851
Submission : 1985-05-20
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5793
Submission : 1985-04-10
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4390
Submission : 1982-01-14
Status : Inactive
Type : II
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7653
Submission : 1988-08-24
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seqens
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharm-RX Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Boai NKY Pharmaceuticals Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Aeon Procare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Avesta Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Bioplus Life Sciences
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Clariant
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures Pvt Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kima Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Bold Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nomisma Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qianhao Chemical (Hebei) Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Welltone Material Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shijiazhuang Huaxu Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]The Dow Chemical Company
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ulanqab Kema New Material
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Valens Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Vasa Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Zhejiang Huakang Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Fillers, Diluents & Binders
Coating Systems & Additives
Thickeners and Stabilizers
Direct Compression
Controlled & Modified Release
Taste Masking
Solubilizers
Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.
Dosage Form : Capsule, Cream / Lotion / Ointment, Emulsion, Gel, Injectable / Parenteral, Suspension, Tablet
Grade : Parenteral, Oral, Topical
Category : Emulsifying Agents, Film Formers & Plasticizers, Parenteral, Solubilizers, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Application : Emulsifying Agents, Film Formers & Plasticizers, Parenteral, Solubilizers, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Excipient Details : Polysorbate 80 is used as a plasticizer, solubilizer, emulsifier, surfactant, and suspension stabilizer. It is also used in parenteral products.
Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.
Dosage Form : Capsule, Cream / Lotion / Ointment, Gel, Injectable / Parenteral, Solution, Tablet
Grade : Parenteral, Topical, Oral
Category : Fillers, Diluents & Binders, Film Formers & Plasticizers, Lubricants & Glidants, Parenteral, Solubilizers, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Brand Name : Polyethylene Glycol 4000
Application : Fillers, Diluents & Binders, Film Formers & Plasticizers, Lubricants & Glidants, Parenteral, Solubilizers, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Excipient Details : PEG 4000 is used as a thickener & suspending agent in suspension injections. It is also used as plasticizer, binder, lubricant & solubilizer.
Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.
Dosage Form : Emulsion, Injectable / Parenteral
Grade : Parenteral
Category : Emulsifying Agents, Parenteral, Solubilizers
Application : Emulsifying Agents, Parenteral, Solubilizers
Excipient Details : Soya lecithin is used as solubilizer & emulsifier in parenteral dosage forms such as fat emulsion injections, mixed micelle preparations & emulsions.
Dosage Form : Cream / Lotion / Ointment, Gel, Solution
Grade : Oral, Topical
Category : Emulsifying Agents, Solubilizers, Topical
Application : Emulsifying Agents, Solubilizers, Topical
Excipient Details : Hydrosol 50 is used as a solubilizer and emulsifying agent in oral and topical liquid and semi-solid dosage forms.
Pharmacopoeia Ref : USP/NF
Technical Specs : N/A
Ingredient(s) : Polyoxyl 40 Hydrogenated Castor Oil
Application : Fillers, Diluents & Binders
Excipient Details : It is used as an adhesive agent.
Pharmacopoeia Ref : Not Available
Technical Specs : Also Available as K17, K25, K90 and VA-64
Ingredient(s) : Povidone 30
Dosage Form : Capsule, Cream / Lotion / Ointment, Emulsion, Injectable / Parenteral, Tablet
Grade : Oral, Topical & Parenteral
Category : Emulsifying Agents, Parenteral, Solubilizers, Topical
Brand Name : PEG/Macrogol 4000
Application : Emulsifying Agents, Parenteral, Solubilizers, Topical
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Polyethylene Glycol 4000
Dosage Form : Tablet, Capsule, Granule / Pellet, Injectable / Parenteral
Grade : Oral, Topical
Category : API Stability Enhancers, Fillers, Diluents & Binders, Lubricants & Glidants, Solubilizers
Application : API Stability Enhancers, Fillers, Diluents & Binders, Lubricants & Glidants, Solubilizers
Excipient Details : Povidone K30 is mainly used as binder for tablet and pellet,dissolving assistant for injection,flow assistant for capsule,dispersant for liquid medicine etc.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Vinylpyrrolidone Excipient
Dosage Form : Capsule, Cream / Lotion / Ointment, Suspension, Tablet
Grade : Oral, Topical & Parenteral
Category : Solubilizers, Surfactant & Foaming Agents
Application : Solubilizers, Surfactant & Foaming Agents
Excipient Details : Polysorbate 80 acts as solubilizer, emulsifier and wetting agent.
Brand Name : AFFINISOL HPMC HME
Application : Solubilizers
Excipient Details : Solubility enhancement, Spray-Dried Dispersion (SDD), Hot Melt Extrusion (HME)
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methylcellulose
Dosage Form : Gel, Softgel Capsule, Solution, Suppository
Grade : Not Available
Category : Solubilizers
Application : Solubilizers
Excipient Details : Nonionic solubilizer, emulsifier and co-emulsifier
Parenteral
Film Formers & Plasticizers
Topical
Disintegrants & Superdisintegrants
Co-Processed Excipients
Chewable & Orodispersible Aids
Lubricants & Glidants
Granulation
SPI Pharma has been solving formulation challenges using superior functional materials.
Dosage Form : Granule / Pellet, Tablet
Grade : Oral
Category : Fillers, Diluents & Binders, Granulation
Application : Fillers, Diluents & Binders, Granulation
Excipient Details : Mannogem (mannitol powder) is a pharmaceutical excipient that dissolves rapidly and increases tablet disintegration rate, drug dissolution & release.
Dosage Form : Tablet
Grade : Oral
Category : Direct Compression, Fillers, Diluents & Binders, Granulation
Application : Direct Compression, Fillers, Diluents & Binders, Granulation
Excipient Details : AceCel is suitable for majority of the directly compressible actives, combines good flow and high compressibility.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Microcrystalline Cellulose
Dosage Form : Capsule, Orodispersible Tablet, Tablet
Grade : Not Available
Category : Controlled & Modified Release, Granulation, Taste Masking
Application : Controlled & Modified Release, Granulation, Taste Masking
Excipient Details : Moisture barrier, Multi particulates, Dry powder layering, Granulation, Hot melt extrusion, Taste Masking, Controlled / Modified Release
Dosage Form : Tablet
Grade : Oral
Category : Direct Compression, Disintegrants & Superdisintegrants, Granulation
Application : Direct Compression, Disintegrants & Superdisintegrants, Granulation
Excipient Details : Croscarmellose sodium, a cellulose-based super disintegrant, provides excellent results in tablet disintegration. It is used in both wet granulation and direct compression.
Dosage Form : Tablet
Grade : Oral
Category : Direct Compression, Fillers, Diluents & Binders, Granulation
Application : Direct Compression, Fillers, Diluents & Binders, Granulation
Excipient Details : HiCel acts as a strong & dry binder. It facilitates low tablet friability & promotes rapid tablet disintegration.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Microcrystalline Cellulose
Application : Fillers, Diluents & Binders, Granulation
Excipient Details : Fully Pregel Starch Corn is used as a binder in wet granulation in the manufacturing of tablets.
Pharmacopoeia Ref : USP/NF, Ph. Eur., Ch. P.
Technical Specs : NA
Ingredient(s) : Corn Starch, Pregelatinized
Application : Fillers, Diluents & Binders, Granulation
Grade : Not Available
Category : API Stability Enhancers, Coating Systems & Additives, Controlled & Modified Release, Direct Compression, Granulation, Rheology Modifiers, Vegetarian Capsules
Application : API Stability Enhancers, Coating Systems & Additives, Controlled & Modified Release, Direct Compression, Granulation, Rheology Modifiers, Vegetarian Capsules
Excipient Details : Controlled Release, Direct Compression,Wet Granulation,Tablet Coating, Liquid Solutions and Suspensions
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methylcellulose
Dosage Form : Tablet
Grade : Oral
Category : Coating Systems & Additives, Fillers, Diluents & Binders, Granulation
Brand Name : Hydroxypropyl Methyl Cellulose (60E3)
Application : Coating Systems & Additives, Fillers, Diluents & Binders, Granulation
Excipient Details : Hydroxypropyl Methyl Cellulose (60E3) is used as a binding, coating, and granulating agent for the production of tablets.
Application : Disintegrants & Superdisintegrants, Granulation
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Croscarmellose Sodium
Emulsifying Agents
Empty Capsules
API Stability Enhancers
Rheology Modifiers
Coloring Agents
Vegetarian Capsules
Surfactant & Foaming Agents
Soft Gelatin
Market Place
APIs
Reply
01 Mar 2024
Reply
19 Jan 2023
Reply
05 Jul 2022
Reply
23 Apr 2022
Reply
25 Jan 2022
Reply
03 Nov 2020
Reply
12 May 2020
Reply
19 Sep 2019
Reply
21 Jan 2016
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
REF. STANDARDS & IMPURITIES
USP
Beta Carotene System Suitability (200 mg) (CO...
CAS Number : N/A
Quantity Per Vial :
Price ($) : 235
Catalog Number : 1065491
Current Lot : F0K128
Previous Lot :
NDC Code :
Beta Carotene (7 x 100 mg) (COLD SHIPMENT REQ...
CAS Number : 7235-40-7
Quantity Per Vial :
Price ($) : 225
Catalog Number : 1065480
Current Lot : G0M537
Previous Lot : F0J240 (30-JUN-2016)
NDC Code :
Meso-Zeaxanthin (5x 30 mg) (Beta-Beta-Caroten...
CAS Number : 31272-50-1
Quantity Per Vial :
Price ($) : 200
Catalog Number : 1733119
Current Lot : F0K295
Previous Lot :
NDC Code :
Others
CAS Number : 7235-40-7
Quantity Per Vial : 700
Sale Unit : mg
Price : $245.00
Details : Material Origin- Chemical Synthesis; USMCA- N...
Monograph :
Storage : Cold Shipment Required
Code/Batch No : Catalog #1065480 / R096S0
Beta Carotene System Suitability (200 mg)
CAS Number :
Quantity Per Vial : 200
Sale Unit : mg
Price : $263.00
Details : Material Origin- Plant; USMCA- No; KORUS- No
Monograph :
Storage : Cold Shipment Required
Code/Batch No : Catalog #1065491 / F0K128
CAS Number :
Quantity Per Vial : 300
Sale Unit : mg
Price : $284.00
Details : Material Origin- Plant; USMCA- No; KORUS- No
Monograph :
Storage :
Code/Batch No : Catalog #1012288 / F059U0
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ANALYTICAL
Analytical Methods
Product Code : AA12S05-1546WT
Classification : Vitamins
Product Characteristics : G910523Q
Category :
Description :
ABOUT THIS PAGE
A Beta Carotene manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Beta Carotene, including repackagers and relabelers. The FDA regulates Beta Carotene manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Beta Carotene API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Beta Carotene manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Beta Carotene supplier is an individual or a company that provides Beta Carotene active pharmaceutical ingredient (API) or Beta Carotene finished formulations upon request. The Beta Carotene suppliers may include Beta Carotene API manufacturers, exporters, distributors and traders.
click here to find a list of Beta Carotene suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Beta Carotene DMF (Drug Master File) is a document detailing the whole manufacturing process of Beta Carotene active pharmaceutical ingredient (API) in detail. Different forms of Beta Carotene DMFs exist exist since differing nations have different regulations, such as Beta Carotene USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Beta Carotene DMF submitted to regulatory agencies in the US is known as a USDMF. Beta Carotene USDMF includes data on Beta Carotene's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Beta Carotene USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Beta Carotene suppliers with USDMF on PharmaCompass.
A Beta Carotene CEP of the European Pharmacopoeia monograph is often referred to as a Beta Carotene Certificate of Suitability (COS). The purpose of a Beta Carotene CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Beta Carotene EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Beta Carotene to their clients by showing that a Beta Carotene CEP has been issued for it. The manufacturer submits a Beta Carotene CEP (COS) as part of the market authorization procedure, and it takes on the role of a Beta Carotene CEP holder for the record. Additionally, the data presented in the Beta Carotene CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Beta Carotene DMF.
A Beta Carotene CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Beta Carotene CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Beta Carotene suppliers with CEP (COS) on PharmaCompass.
Beta Carotene Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Beta Carotene GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Beta Carotene GMP manufacturer or Beta Carotene GMP API supplier for your needs.
A Beta Carotene CoA (Certificate of Analysis) is a formal document that attests to Beta Carotene's compliance with Beta Carotene specifications and serves as a tool for batch-level quality control.
Beta Carotene CoA mostly includes findings from lab analyses of a specific batch. For each Beta Carotene CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Beta Carotene may be tested according to a variety of international standards, such as European Pharmacopoeia (Beta Carotene EP), Beta Carotene JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Beta Carotene USP).
LOOKING FOR A SUPPLIER?
Comment (5)
